Wednesday, September 22, 2021

Kip Piper's Health Care Blog
Medicare, Medicaid, Health Reform

Home Pharma and Biotech

Pharma and Biotech

The life sciences companies are looking for new board members and senior executives - and today's challenging business, payor, and regulatory environment requires new skills.  In a new episode of the MediStrategy podcast, learn how pharmaceutical, biotechnology, medical diagnostics, and medical device firms find new board directors, chief executive...
Global drug pricing continues to ignite fresh controversies as health policy makers, government health programs, health insurers, and pharmaceutical companies meet in heated debate. Solutions for health around the world rely on stakeholders having a clear understanding of the structure and logic behind drug pricing, but the complexities of the...
The research and development pipeline for drugs and biologics is experiencing a tremendous surge in innovation, which will come to fruition within the next five years. This surge in prescription medicines will parallel a number of technology-enabled transformations in health care delivery that will dramatically increase access to health...
The medical goal for children diagnosed with pediatric cancers is remission or cure, but consistency and speediness of health insurance coverage is critical to access to preferred treatment. The therapeutic intervention differs based on the cancer type, stage, tolerance of the child to radiation and pharmaceutical agents, and numerous...
Real-World Evidence for Drugs, Biologics, Medical Diagnostics, and Devices. Blog post by Kip Piper.
Insights from Experts Convened by the U.S. Food and Drug Administration (FDA) and the National Academies of Sciences, Engineering, and Medicine. Historically, randomized controlled trials have been used to determine the effectiveness and potential uses of biopharmaceutical products and medical treatments. These...
Use of Medicines in 2019 and Forecasts for 2023 Drugs and Biologics
Biopharmaceutical Spending Increasing but at Slower Annual Growth Rate  The pharmaceutical market is set to reach $1.5 trillion globally by the year 2023, according to a new report by the IQVIA Institute for Human Data Science and entitled The Global Use of Medicine in...

Stay Connected

4,688FansLike
6,936FollowersFollow
21,503FollowersFollow

Latest Articles